Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Healthcare Facilities & Services

Real-time Euronext Paris 04:39:35 2024-04-25 am EDT 5-day change 1st Jan Change
56.92 EUR +0.14% Intraday chart for Eurofins Scientific SE -5.26% -3.49%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
CAC40: interest rates soar, pulling back below 8100 pts CF
EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed Alphavalue
CAC40: reverses course under pressure from rates at their zenith CF
CAC40: rise to 8.150, but interest-rate tensions hinder progress CF
Transcript : Eurofins Scientific SE, Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024
CAC40: close to equilibrium despite Kering's plunge CF
Eurofins: organic growth close to 7% in Q1 CF
CAC40: up sharply, back over 8100 pts CF
CAC40: week ends at half-mast, gold at its zenith CF
CAC40: pullback reduced, WStreet +0.7%, Brent at $91, Gold at $233 CF
CAC40: easily preserves 8,000Pts, NFP has no impact CF
CAC40: ends the day balanced after a salvo of statistics CF
CAC40: frozen at 8,155, W-Street well disposed, gold at its zenith CF
CAC40: indecisive towards 8,160, W-Street climbs back to the top CF
EUROFINS SCIENTIFIC : Berenberg raises its price target CF
CAC40: up slightly after PMI figures CF
Eurofins Scientific to Purchase US-based Ascend Clinical MT
Eurofins completes acquisition of Ascend Clinical CF
Eurofins Scientific SE acquired Ascend Clinical, LLC. CI
CAC40: ends with a balanced performance, helped by the banking sector CF
CAC40: all-time high, tackles 8250 resistance level CF
European Equities Close Mixed in Monday Trading; Real Estate, Pharmaceutical Stocks Rise MT
CAC40: insignificant decline in limited volumes CF
Enzymatica Obtains CE Marking for ColdZyme Mouth Spray MT
CAC40: zero reaction to US PCE, but February ends on a high note CF
Chart Eurofins Scientific SE
More charts
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
56.84 EUR
Average target price
60 EUR
Spread / Average Target
+5.56%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ERF Stock
  4. News Eurofins Scientific SE
  5. Eurofins Scientific : Prices $909.6 Million Senior Unsecured Bonds